Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty.
暂无分享，去创建一个
[1] Xiu-ying Jin,et al. Local therapy of corneal allograft rejection with cyclosporine. , 1995, American journal of ophthalmology.
[2] J. Hill,et al. Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy. , 1994, Ophthalmology.
[3] O. Ozden,et al. Therapeutic use of topical cyclosporine. , 1993, Annals of ophthalmology.
[4] M. Belin,et al. Update on topical cyclosporin A. Background, immunology, and pharmacology. , 1990, Cornea.
[5] H. Thiel,et al. The use of cyclosporine in high-risk keratoplasty. , 1989, American journal of ophthalmology.
[6] M. Belin,et al. Topical cyclosporine in high-risk corneal transplants. , 1989, Ophthalmology.
[7] Arthur N. L. Chiu,et al. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation. , 1989, Transplantation proceedings.
[8] J. Rakela,et al. Conversion from standard cyclosporine to low-dose cyclosporine in liver transplant recipients: effect on nephrotoxicity and hypertension beyond one year. , 1989, Transplantation proceedings.
[9] D. Niederwieser,et al. Successful engraftment of high-risk corneal allografts with short-term immunosuppression with cyclosporine. , 1988, Transplantation.
[10] A. Silverstein,et al. Transplantation and rejection of individual cell layers of the cornea. , 1969, Investigative ophthalmology.